Concepedia

Dilini Gunatilake

DG

11

Publications

753

Citations

11

H-Index

2014

Active since

Affiliations

Melanoma Institute Australia(Current)

The University of Sydney

Peter MacCallum Cancer Centre

Centenary Institute

Westmead Institute

Dilini Gunatilake is an author at Melanoma Institute Australia specializing in medicine, tumor biology, and cell biology.

ORCID

Top concepts

Publications per year

2014–2023

11

Publications

11

Inducible but Not Constitutive Expression of PD-L1 in Human Melanoma Cells Is Dependent on Activation of NF-κB

Kavitha Gowrishankar, Dilini Gunatilake, Stuart Gallagher et al. · PLoS ONE · 2015 · 220 citations · Full text

, , +22

Combining BET and HDAC inhibitors synergistically induces apoptosis of melanoma and suppresses AKT and YAP signaling

Anja Heinemann, Carleen Cullinane, Ricardo De Paoli‐Iseppi et al. · Oncotarget · 2015 · 86 citations · Full text

Targeting activating mutations of EZH2 leads to potent cell growth inhibition in human melanoma by derepression of tumor suppressor genes

Jessamy Tiffen, Dilini Gunatilake, Stuart Gallagher et al. · Oncotarget · 2015 · 82 citations · Full text

Control of <scp>NF</scp>‐<scp>kB</scp> activity in human melanoma by bromodomain and extra‐terminal protein inhibitor <scp>I</scp>‐<scp>BET</scp>151

Stuart Gallagher, Branka Mijatov, Dilini Gunatilake et al. · Pigment Cell & Melanoma Research · 2014 · 81 citations

The Epigenetic Regulator I-BET151 Induces BIM-Dependent Apoptosis and Cell Cycle Arrest of Human Melanoma Cells

Stuart Gallagher, Branka Mijatov, Dilini Gunatilake et al. · Journal of Investigative Dermatology · 2014 · 63 citations · Full text

, , +10

Rows per page

1–5 of 11